23andMe’s Parkinson’s Research Community is by far the world’s largest re-contactable deeply phenotyped cohort for Parkinson’s disease research.
Over the last decade data from this community has contributed significantly to the discovery of 90 genetic variants associated with Parkinson’s disease. These findings give scientists potential pathways for future research and insight into possible new drug targets to treat Parkinson’s.
23andMe researchers have also identified more than 100 phenotypic — or non-genetic traits or characteristics — associations with Parkinson’s, offering the potential of earlier detection of the disease. 23andMe researchers and our collaborators have published dozens of papers on our findings around Parkinson’s disease, and have opened an online portal to provide qualified Parkinson’s researchers access to its aggregate-level, de-identified data.
October Insights into Parkinson’s Research
An update on recruitment for the Fox Insights Parkinson's research initiative.
Read More
23andMe employees come together to raise awareness for Parkinson’s disease
At 23andMe, we are committed to accelerating and advancing Parkinson’s disease research. So when April comes around, employees make a point of honoring Parkinson’s Awareness Month.As we’ve done in the...
Read More
Update on 23andMe Parkinson’s disease research
Participants in the 23andMe Parkinson’s disease research initiative have contributed a vast amount of data, that has enabled our researchers and collaborators to improve our understanding of the genetics of...
Read More
New Genetic Associations for Parkinson’s Disease Identified
Scientists at 23andMe and Genentech have identified 17 new genetic variants associated with Parkinson’s disease, almost doubling the total number of known risk variants for the condition, which gives scientists hints at potential new targets for drugs to treat the disease.
Read More
Parkinson’s Research Community Update
23andMe Parkinson's disease researchers plan to collect new types of data for their work.
Read More
Parkinson’s Awareness Month
April is Parkinson’s Awareness Month and this year it also marks the eighth anniversary of 23andMe’s Parkinson’s Research Community, which introduced a game-changing model for science, one that leverages online...
Read More
International Parkinson’s Meeting News
After four days in Berlin attending the massive annual meeting of the International Parkinson’s and Movement Disorders Society, 23andMe Parkinson’s Community manager, Paul Cannon, PhD, came back hopeful for the...
Read More
Ali and Parkinson’s
In his last fight– the one against Parkinson’s – Muhammad Ali went the distance finally succumbing in early June to complications from a respiratory problem.He was 74. In the more...
Read More
Everyday Hero
There are many faces of Parkinson’s, Claudia’s just happens to be smiling most of the time. “I’m an optimistic person,” said the mother of two teenage boys who lives with...
Read More
April is Parkinson’s Awareness Month
To mark Parkinson’s Awareness Month, we’re taking a moment to look at some of the accomplishments 23andMe has made in the study of the disease in a relatively short time....
Read More